CD274 and thyroid gland undifferentiated (anaplastic) carcinoma: Combination therapy with PLX4720 and anti-PD-1/PD-L1 antibody reduces tumour volume and leads to improved survival in an immunocompetent orthotopic murine model of anaplastic thyroid cancer